Status:
COMPLETED
Percutaneous High Frequency Alternating Current Stimulation in Healthy Volunteers
Lead Sponsor:
University of Castilla-La Mancha
Conditions:
Electrical Stimulation
Neuromodulation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
High-frequency alternating currents of greater than 1 kHz applied on peripheral nerves has been used in animal studies to produce a motor nerve block. It has been evidenced that frequencies higher tha...
Detailed Description
Our previous studies with transcutaneous HFAC, suggest high-frequency stimulation (10 and 20 kHz) have an inhibitory effect over muscle strength and somatosensory threshold. However, in these studies...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Ability to perform all clinical tests and understand the study process, as well as obtaining informed consent.
- Tolerance to the application of electrotherapy.
- That they have not diagnosed any pathology.
- They do not present a contraindication to puncture and / or the application of electric currents.
Exclusion
- Neuromuscular disease.
- Epilepsy.
- Trauma, surgery or pain affecting the upper limb
- Osteosynthesis material in the upper limb.
- Diabetes.
- Cancer.
- Cardiovascular disease.
- Pacemaker or other implanted electrical device.
- Take any drug (NSAIDs, corticosteroids, antidepressants, analgesics, antiepileptics, ...) during the study and in the previous 7 days.
- Presence of tattoos or other external agent introduced into the treatment or assessment area.
- Pregnancy
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04346719
Start Date
June 1 2020
End Date
November 17 2020
Last Update
November 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Castilla-La Mancha University
Toledo, Spain, 45071